The reported experiments explore the effects of peripheral LPS administration on learning and memory processes. As measured by the conditioned freezing response, intraperitoneal LPS administration given after conditioning impaired contextual but not auditory-cue fear conditioning in both juvenile (hooded Long Evans) and adult rats (albino Sprague Dawley) of two different strains. This impairment in contextual fear conditioning was not dependent on the presence of the tone. Preexposure to the context eliminated the effect of LPS on contextual fear conditioning, and in addition, LPS given after context preexposure negated the beneficial effects of preexposure on contextual fear. These results suggest that LPS disrupts posttrial memory consolidation processes. In support of the hypothesis that LPS-induced proinflammatory cytokine release is involved in producing the impairment in contextual fear caused by LPS, peripheral interleukin-1 receptor antagonist (IL1ra) administered subcutaneously at a dose of 100 mg/kg prevented the impairment in contextual fear caused by LPS. These experiments provide evidence for a role of immune activation and cytokine activity in learning and memory processes.
Activation of peripheral immune cells by lipopolysaccharide (LPS), or the peripheral administration of proinflammatory cytokines that are induced by LPS, produce a constellation of behavioral and physiological adjustments called ''sickness behavior '' (Dantzer, Bluthe, Kent, & Kelley, 1991) . These changes include decreased food and water intake, decreased exploration, decreased social interaction, increased sleep, fever, hyperalgesia, hypothalamo-pituitary-adrenal activation, and increased sympathetic activity. Many of these sickness responses are mediated by the central nervous system, rather than by direct action at the periphery (Maier & Watkins, 1997) . Peripheral immune activation leads to a variety of neurochemical changes (Dunn, 1992; Linthorst, Flachskamm, Muller-Preuss, Holsboer, & Reul, 1995) , and brain IL-1β may play an important role in this process. This view is held because (a) peripheral immune activation by lipopolysaccharide (LPS) induces IL-1β mRNA (Ban, Haour, & Lenstra, 1992; Laye, Parnet, Goujon, & Dantzer, 1992) and IL-1β bioactivity (Quan, Sundar, & Weiss, 1994) , (b) intracerebroventricular (i.c.v.) and regional IL-1β microinjections produce many aspects of the sickness response, including leukocytosis and the production of hepatic acute phase proteins (Morimoto, Murakami, Nakamori, Sakata, & Watanabe, 1989; Morimoto, Watanabe, Sakata, & Murakami, 1988) , and (c) IL-1β receptor antagonists reduce or eliminate many changes induced by peripheral immune stimulation such as hypothalamic-pituitary-adrenal axis activation (Kakucska, Qi, Clark, & Lechan, 1993) , the suppression of food and water intake (Plata-Salaman & French-Mullen, 1992) , and increased serotonin release in the hippocampus (Linthorst et al., 1995) .
